MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results
November 05, 2024 16:01 ET
|
MacroGenics, Inc.
Strengthened financial position resulting from recently announced MARGENZA® transaction and previously announced receipt of milestone payment from Incyte related to advancement of ZYNYZ®ADAM9-directed...
DART Orange Line celebrates decade of taking riders in and out of DFW Airport with direct rail service
August 16, 2024 18:11 ET
|
Dallas Area Rapid Transit (DART)
DALLAS, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Recent local transit conversation has focused on the Dallas Area Rapid Transit (DART) Silver Line Regional Rail project and its ability to connect future...
[Latest] Global Paper Cups Market Size/Share Worth USD 13.2 Billion by 2033 at a 4.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
June 26, 2024 11:30 ET
|
Custom Market Insights
Austin, TX, USA, June 26, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Paper Cups Market Size, Trends and Insights By Cup Capacity (Up to 150 ml, 151...
MacroGenics Provides Update on Corporate Progress and 2023 Financial Results
March 07, 2024 16:01 ET
|
MacroGenics, Inc.
Presentation of preliminary data from TAMARACK Phase 2 study of vobra duo in mCRPC patients expected at ASCO 2024Initiation of Phase 1 study of MGC026, MacroGenics' first topoisomerase I...
MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program
September 05, 2023 07:00 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Sept. 05, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based...
MacroGenics Announces Preliminary Clinical Results from Single Arm Study of Lorigerlimab in Patients with Metastatic Castration-Resistant Prostate Cancer to be Presented at ASCO Genitourinary Cancers Symposium
February 13, 2023 17:20 ET
|
MacroGenics, Inc.
Twelve of 42 patients (28.6%) in metastatic castration-resistant prostate cancer (mCRPC) cohort achieved ≥ 50% prostate-specific antigen (PSA) reduction (PSA50), including 9 (21.4%) who achieved ≥ 90%...
MacroGenics Announces MGD019 Publication in Cell Reports Medicine
December 22, 2020 11:35 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Dec. 22, 2020 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based...
MacroGenics Enters Research Collaboration with Janssen to Develop Novel DART® Molecule
December 18, 2020 07:30 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Dec. 18, 2020 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based...
Inotiv Launches Website for Newly Unified Contract Research Services
February 12, 2020 09:18 ET
|
Bioanalytical Systems, Inc.
WEST LAFAYETTE, Ind., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ: BASI), operating as Inotiv (the “Company” or “Inotiv”), is pleased to announce the launch of its new...
BASi Acquires the Smithers Avanza Toxicology Services Business Unit to Support Growing Toxicology Business and Broaden Scientific Talent
May 01, 2019 09:30 ET
|
Bioanalytical Systems, Inc.
WEST LAFAYETTE, Ind., May 01, 2019 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc., (NASDAQ:BASI) (“BASi” or the “Company”) today announced its acquisition of the Smithers Avanza Toxicology Services...